Last reviewed · How we verify

NCT03572322: ORGAGENE

Genetics Tests : How to Improve Management Within Two Medical Specialities

Completed Last updated 19 April 2023
What this trial tests

trial testing Focus Group in Genetics in 36 participants. Completed in 13 April 2022.

Timeline
18 September 2017
Primary endpoint
13 April 2022
13 April 2022

Quick facts

Lead sponsorRennes University Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment36
Start date18 September 2017
Primary completion13 April 2022
Estimated completion13 April 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Rennes University Hospital

Who can join

18 and older, any sex, with Genetics or Diagnostic Techniques and Procedures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This survey will assess discrepancies between official clinical genetics guidelines and practices within 3 West regions of France.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. How do non-geneticist physicians deal with genetic tests? A qualitative analysis.
    Pasquier L, Minguet G, Moisdon-Chataigner S, Jarno P, et al · · 2022 · cited 10× · PMID 33907318 · DOI 10.1038/s41431-021-00884-z

Verify or expand the search:

Other trials of Focus Group

Trials testing the same drug.

Other recruiting trials for Genetics

Currently open trials in the same condition.

Other Rennes University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03572322.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing